Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells

被引:22
作者
Liu, Bin
Shi, Yufeng
Peng, Wending
Zhang, Qingyu
Liu, Jie
Chen, Nianping [1 ,2 ]
Zhu, Runzhi [1 ,2 ]
机构
[1] Guangdong Med Univ, Lab Hepatobiliary Surg, 57 Renmin Rd, Zhanjiang 524001, Guangdong, Peoples R China
[2] Guangdong Med Univ, Zhanjiang Key Lab Hepatobiliary Dis, Affiliated Hosp, 57 Renmin Rd, Zhanjiang 524001, Guangdong, Peoples R China
关键词
diosmetin; TGF-beta; HepG2; apoptosis; HEPATOCELLULAR-CARCINOMA; FLAVONOIDS DIOSMETIN; ANTIOXIDANT ACTIVITY; NATURAL-PRODUCTS; PROGRESSION; METABOLISM; ACTIVATION;
D O I
10.3892/mmr.2016.5258
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diosmetin (Dio) is a major active component of flavonoid compounds. A previous study demonstrated that Dio exhibited anticancer activity and induced apoptosis in HepG2 human hepatoma cells via cytochrome P450, family 1-catalyzed metabolism. The present study observed that cell proliferation of HepG2 cells was inhibited by Dio treatment and tumor protein p53 was significantly increased following Dio treatment. Following addition of recombinant transforming growth factor-beta (TGF-beta) protein to Dio-treated HepG2 cells, cell growth inhibition and cell apoptosis was partially reversed. These findings suggest a novel function for the TGF-beta/TGF-beta receptor signaling pathway and that it may be a key target of Dio-induced cell apoptosis in HepG2 cells.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 28 条
[1]   Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450 [J].
Androutsopoulos, Vasilis ;
Wilsher, Nicola ;
Arroo, Randolph R. J. ;
Potter, Gerry A. .
CANCER LETTERS, 2009, 274 (01) :54-60
[2]   The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation [J].
Androutsopoulos, Vasilis P. ;
Spandidos, Demetrios A. .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2013, 24 (02) :496-504
[3]   CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells [J].
Androutsopoulos, Vasilis P. ;
Ruparelia, Ketan ;
Arroo, Randolph R. J. ;
Tsatsakis, Aristidis M. ;
Spandidos, Demetrios A. .
TOXICOLOGY, 2009, 264 (03) :162-170
[4]   Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation [J].
Androutsopoulos, Vasilis P. ;
Mahale, Sachin ;
Arroo, Randolph R. J. ;
Potter, Gerry .
ONCOLOGY REPORTS, 2009, 21 (06) :1525-1528
[5]   Flavonoids and antioxidant activity of Rosa agrestis leaves [J].
Bitis, Leyla ;
Kultur, Sukran ;
Melikoglu, Gulay ;
Ozsoy, Nurten ;
Can, Ayse .
NATURAL PRODUCT RESEARCH, 2010, 24 (06) :580-589
[6]   Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression [J].
Brady, Colleen A. ;
Jiang, Dadi ;
Mello, Stephano S. ;
Johnson, Thomas M. ;
Jarvis, Lesley A. ;
Kozak, Margaret M. ;
Broz, Daniela Kenzelmann ;
Basak, Shashwati ;
Park, Eunice J. ;
McLaughlin, Margaret E. ;
Karnezis, Anthony N. ;
Attardi, Laura D. .
CELL, 2011, 145 (04) :571-583
[7]   Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro [J].
Burmakin, Mikhail ;
Shi, Yao ;
Hedstrom, Elisabeth ;
Kogner, Per ;
Selivanova, Galina .
CLINICAL CANCER RESEARCH, 2013, 19 (18) :5092-5103
[8]   Role of TGF-β in Melanoma [J].
Busse, A. ;
Keilholz, U. .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) :2165-2175
[9]  
Ciolino HP, 1998, CANCER RES, V58, P2754
[10]   TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis [J].
Drabsch, Yvette ;
ten Dijke, Peter .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2011, 16 (02) :97-108